Sign In
Buy DXR
$10.50
-0.345 (-3.18%)
At Close: Jul 31, 2026
Blood Volume Analysis (BVA) in 83-Patient Study Provided Highly Effective Guidance for Care of Heart Failure Patients Otherwise Unavailable Using Common Proxy Diagnostic Methods
Daxor Corporation Awarded Support from the National Institutes of Health (NIH) Catalyze Preclinical Services Program
08:00am, Wednesday, 04'th Oct 2023
Support for Development of Daxor's Non-Nuclear Tracer for Next Generation Blood Volume Analyzer Systems Aims to Deliver Gold Standard Accuracy with Increased Access, Ease of Use, and Frequency of Test
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2023
08:00am, Wednesday, 27'th Sep 2023
Daxor's Blood Volume Technology Featured at Scientific Session Oak Ridge, TN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technolo
Oak Ridge, TN, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Daxor C orporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announced that the National Institutes of Health (NI
Daxor Corporation to Present at the H.C. Wainwright 25th Annual Global Investment Conference
09:15am, Thursday, 07'th Sep 2023
Oak Ridge, TN, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh w
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
04:15pm, Monday, 28'th Aug 2023
Oak Ridge, TN, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today issued a corporate update in a Letter to Shareholders
Net Assets Increases to $30.4 Million From $29.0 Million Oak Ridge, TN, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, ann
Daxor Corporation (DXR) Q4 2022 Earnings Call Transcript
03:04pm, Monday, 06'th Mar 2023
Daxor Corporation (NASDAQ:DXR ) Q4 2022 Results Conference Call March 2, 2023 9:00 AM ET Company Participants Scott Gordon - President, Core IR Michael Feldschuh - CEO Robert Michel - CFO Conference C
Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option
04:07pm, Thursday, 17'th Nov 2022 GlobeNewswire Inc.
Oak Ridge, TN, Nov. 17, 2022 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the c
Dow Surges More Than 300 Points After Producer Prices Increase Less Than Expected
03:12pm, Tuesday, 15'th Nov 2022 Benzinga
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Tuesday.
Following the market opening Tuesday, the Dow traded up 0.91% to 33,841.32 while the NASDAQ rose 2.0
Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering
01:45pm, Tuesday, 15'th Nov 2022 GlobeNewswire Inc.
Oak Ridge, TN, Nov. 15, 2022 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the p
Daxor Corporation Announces Launch of Proposed Underwritten Public Offering
10:03pm, Monday, 14'th Nov 2022 GlobeNewswire Inc.
Oak Ridge, TN, Nov. 14, 2022 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced that
New Data Shows 85% Reduction In One-Year Mortality For Medicare Heart Failure Patients With BVA-Guided Care
12:40pm, Monday, 03'rd Oct 2022 GlobeNewswire Inc.
Patient One-Year Mortality Rate 5.6% with BVA-Guided Care Compared to 36.8% in Control Group - Data Presented at Key Scientific Meeting
Daxor Corporation to Attend the H.C. Wainwright 24th Annual Global Investment Conference
09:05pm, Tuesday, 06'th Sep 2022 GlobeNewswire Inc.
Oak Ridge, TN, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh
Daxor Corporation to Attend the H.C. Wainwright 24th Annual Global Investment Conference
05:05pm, Tuesday, 06'th Sep 2022
Oak Ridge, TN, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh wi
